USPTO Director Squires’s 2025 policies encourage more use of evidence-based SMEDs to challenge patent rejections, especially ...
The integration of artificial intelligence (AI) and machine learning (ML) into the life sciences field has created exciting new opportunities for advancements in diagnostics, therapeutics, and ...
Patent practitioners have seen a shifting landscape for patent eligibility under 35 U.S.C. § 101 since the Supreme Court’s 2012 and 2014 seminal decisions in Mayo and Alice. Now, the United States ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback